Back
Intellia Therapeutics Stock Predictions
Sponsored
NTLA
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
NTLA
Intellia Therapeutics
Last Price:
22.92
Seasonality Move:
-1.88%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Intellia Therapeutics Stock Forecast
- Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 61.5% based on the past 8 years of stock performance.
- Intellia Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Intellia Therapeutics Stock Undervalued?
The current Intellia Therapeutics [NTLA] share price is $22.52. The Score for NTLA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal. - NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Intellia Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 61.5% based on the past 8 years of stock performance.
Intellia Therapeutics Stock Rating
Sell
29
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics overpriced?
- Intellia Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Intellia Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
intelliatx.com
52-Week Data
52-Week High:
34.94
52-Week Low:
19.21
Prediction Charts
Market Cap:
2.29B
Price in USD:
22.52
Volume:
1.72M
Beta:
2.00
Technical Analysis
SMA50:
23.39
SMA100:
23.59
SMA200:
25.55
52-Wk Change:
-35.69%
Stock Predictions
-
Is Intellia Therapeutics stock public?
Yes, Intellia Therapeutics is a publicly traded company. -
What is the Intellia Therapeutics stock quote today?
The Intellia Therapeutics stock price is 22.52 USD today. -
How to buy Intellia Therapeutics stock online?
You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-29 | 22.49 | 23.00 | 23.50 | 22.34 |
Aug-30 | 23.06 | 22.44 | 23.19 | 21.93 |
Sep-3 | 22.35 | 21.61 | 23.09 | 21.51 |
Sep-4 | 21.72 | 21.27 | 22.15 | 21.07 |
Sep-5 | 21.24 | 20.94 | 21.56 | 20.72 |
Sep-6 | 21.00 | 19.72 | 21.33 | 19.51 |
Sep-9 | 19.85 | 19.83 | 20.14 | 19.52 |
Sep-10 | 19.86 | 20.12 | 20.38 | 19.31 |
Sep-11 | 19.79 | 20.24 | 20.29 | 19.21 |
Sep-12 | 20.20 | 20.67 | 20.68 | 19.61 |
Sep-13 | 21.14 | 22.07 | 22.22 | 21.00 |
Sep-16 | 22.11 | 21.51 | 22.22 | 21.21 |
Sep-17 | 21.81 | 22.55 | 23.15 | 21.77 |
Sep-18 | 23.00 | 22.52 | 23.76 | 22.26 |
Intellia Therapeutics Earnings
Intellia Therapeutics Earnings Report: Per Share Intellia Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intellia Therapeutics Forecast Revenue Growth
Intellia Therapeutics Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.20 per share.
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.